Kaposiform Hemangioendothelioma of the middle ear in a pediatric patient: Outcomes following dual therapy with Sirolimus and Vincristine
International Journal of Pediatric Otorhinolaryngology Case Reports · 2020
DOI: 10.1016/j.pedeo.2020.100681 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pediatric Otorhinolaryngology Case Reports, 2020. Verfasst von Alessandra M. Cataldo und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kaposiform Hemangioendothelioma (KHE) is a rare vascular locally aggressive tumor. The primary treatment is surgical resection, which may be challenging depending on its location and vascularity. Pharmacological treatment includes steroids, vincristine, and recently, Sirolimus (immunosuppressant with anti-proliferative activity). We describe a rare case of refractory KHE located in the middle ear. In addition to its unusual and inoperable anatomical location, this pediatric patient was a non-responder to first line Sirolimus monotherapy. After two months of dual therapy adding Vincristine to the treatment schedule, significant tumor reduction was seen on MRI, with no relapse during the two-year follow-up after completion of treatment.
Zitieren
APA
Cataldo, A. M., Jong, M. A. D., & Gross, M. (2020). Kaposiform Hemangioendothelioma of the middle ear in a pediatric patient: Outcomes following dual therapy with Sirolimus and Vincristine. International Journal of Pediatric Otorhinolaryngology Case Reports. https://doi.org/10.1016/j.pedeo.2020.100681
Vancouver
Cataldo AM, Jong MAD, Gross M. Kaposiform Hemangioendothelioma of the middle ear in a pediatric patient: Outcomes following dual therapy with Sirolimus and Vincristine. International Journal of Pediatric Otorhinolaryngology Case Reports. 2020. doi:10.1016/j.pedeo.2020.100681
BibTeX
@article{Cataldo2020,
author = {Cataldo, Alessandra M. and Jong, Marrigje A. de and Gross, Menachem},
title = {Kaposiform Hemangioendothelioma of the middle ear in a pediatric patient: Outcomes following dual therapy with Sirolimus and Vincristine},
journal = {International Journal of Pediatric Otorhinolaryngology Case Reports},
year = {2020},
doi = {10.1016/j.pedeo.2020.100681}
}
EUVIMED